Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity

DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector
diagram bullet

Check conditions

DIABETES_FG

60969

diagram downward connector
diagram bullet

Filter registries

Operations: NOMESCO codes ^CKD65|^CKD05

2947

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

2947

diagram downward connector

Check minimum number of events None

2947

diagram downward connector

Include endpoints None

2947

diagram downward connector
DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 2947 1225 1722
Unadjusted prevalence (%) 0.83 0.62 1.09
Mean age at first event (years) 64.09 64.53 63.78

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.24 [1.39, 3.61] 9.4e-4 434
15 years 0.01 1.07 [0.72, 1.59] 7.4e-1 173
5 years 0.00 2.78 [2.01, 3.83] 4.8e-10 192
1 year 0.00 3.28 [2.22, 4.87] 3.1e-9 45

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG – Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity
GWS hits:

Survival analyses between endpoints

Plot

before Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity
after Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity